« Back to Record
Citation APA

Bonnefoi, H., Biganzoli, L., Mauriac, L., Cufer, T., Schaefer, P., Atalay, G., & Piccart-Gebhart, M. (2003). An EORTC phase I study of capecitabine (Xeloda) in combination with fixed doses of cyclophosphamide and epirubicin (cex) as primary treatment for large operable or locally advanced/inflammatory breast cancer. European journal of cancer, 39(9), 1277-1283.


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/55259

Bonnefoi, H., Biganzoli, L., Mauriac, L., Cufer, T., Schaefer, P., Atalay, G., & Piccart-Gebhart, M. (2003). An EORTC phase I study of capecitabine (Xeloda) in combination with fixed doses of cyclophosphamide and epirubicin (cex) as primary treatment for large operable or locally advanced/inflammatory breast cancer. European journal of cancer, 39(9), 1277-1283.